Identifier
Created
Classification
Origin
09VIENNA891
2009-07-20 15:13:00
UNCLASSIFIED
Embassy Vienna
Cable title:
AUSTRIA H1N1 UPDATE: 54 CONFIRMED CASES, STILL NO SPECIAL
how-toVZCZCXYZ0000 PP RUEHWEB DE RUEHVI #0891 2011513 ZNR UUUUU ZZH P 201513Z JUL 09 FM AMEMBASSY VIENNA TO RUEHC/SECSTATE WASHDC PRIORITY 3015 INFO RUEHRC/USDA FAS WASHDC 1250 RUEAUSA/DEPT OF HHS WASHDC
UNCLAS VIENNA 000891
SIPDIS
DEPT FOR EUR/CE
STATE FOR OES/IHB
STATE FOR AID/GH/HIDN
USDA PASS TO APHIS
HHS PASS TO CDC
HHS FOR OGHA
E.O. 12958: N/A
TAGS: TBIO ECON ASEC CASC KFLO KPAO KFLU PREL MG AU
SUBJECT: AUSTRIA H1N1 UPDATE: 54 CONFIRMED CASES, STILL NO SPECIAL
PRECAUTIONARY MEASURES
REF: (A) VIENNA 733; (B) VIENNA 519
UNCLAS VIENNA 000891
SIPDIS
DEPT FOR EUR/CE
STATE FOR OES/IHB
STATE FOR AID/GH/HIDN
USDA PASS TO APHIS
HHS PASS TO CDC
HHS FOR OGHA
E.O. 12958: N/A
TAGS: TBIO ECON ASEC CASC KFLO KPAO KFLU PREL MG AU
SUBJECT: AUSTRIA H1N1 UPDATE: 54 CONFIRMED CASES, STILL NO SPECIAL
PRECAUTIONARY MEASURES
REF: (A) VIENNA 733; (B) VIENNA 519
1. As of July 29, Austrian authorities report 54 total H1N1 cases
since the outbreak of the epidemic. The number of infected persons
has increased significantly over the past two weeks. Most cases
have been discovered after Austrians returned home from tourist
destinations all over the world (the six most recent cases over the
weekend are tourists coming home from trips to Australia,
Philippines, Spain and Bulgaria). The course of the disease has
been mild in all cases so far, and the patients have recovered
quickly. Most of the cases are treated with Tamiflu.
2. The Director for Public Health, Hubert Hrabcik emphasized that
there has been no "infection chain" in Austria due to strict
isolation and treatment of infected persons. "At least 100 - 200
new infections have been prevented that way", he told the press. At
this stage, Austria is not planning additional precautionary
measures and is not expecting an epidemic in Austria. The Austrian
pandemic plan foresees that in case of a "serious aggravation" of
the situation those persons, who maintain public health and public
order in Austria (people employed in the health care service,
security, sewage, and transportation sectors, and also policy
makers),are treated first with antiviral medication. With current
Tamiflu stocks around 670,000 inhabitants could be supplied.
3. As reported in ref A, Austria concluded a pre-contract with the
U.S. pharmaceutical company Baxter to supply 16 million vaccine
doses. The Austrian health authorities expect the authorization of
Baxter's H1N1 vaccine (under the brand name "Celvapan") by
September. Baxter has developed its H1N1 vaccine by using its "vero
cell" technology (cell cultures instead of conventional egg-based
systems) in its research facilities in Austria, and is currently in
the production phase.
HOH
SIPDIS
DEPT FOR EUR/CE
STATE FOR OES/IHB
STATE FOR AID/GH/HIDN
USDA PASS TO APHIS
HHS PASS TO CDC
HHS FOR OGHA
E.O. 12958: N/A
TAGS: TBIO ECON ASEC CASC KFLO KPAO KFLU PREL MG AU
SUBJECT: AUSTRIA H1N1 UPDATE: 54 CONFIRMED CASES, STILL NO SPECIAL
PRECAUTIONARY MEASURES
REF: (A) VIENNA 733; (B) VIENNA 519
1. As of July 29, Austrian authorities report 54 total H1N1 cases
since the outbreak of the epidemic. The number of infected persons
has increased significantly over the past two weeks. Most cases
have been discovered after Austrians returned home from tourist
destinations all over the world (the six most recent cases over the
weekend are tourists coming home from trips to Australia,
Philippines, Spain and Bulgaria). The course of the disease has
been mild in all cases so far, and the patients have recovered
quickly. Most of the cases are treated with Tamiflu.
2. The Director for Public Health, Hubert Hrabcik emphasized that
there has been no "infection chain" in Austria due to strict
isolation and treatment of infected persons. "At least 100 - 200
new infections have been prevented that way", he told the press. At
this stage, Austria is not planning additional precautionary
measures and is not expecting an epidemic in Austria. The Austrian
pandemic plan foresees that in case of a "serious aggravation" of
the situation those persons, who maintain public health and public
order in Austria (people employed in the health care service,
security, sewage, and transportation sectors, and also policy
makers),are treated first with antiviral medication. With current
Tamiflu stocks around 670,000 inhabitants could be supplied.
3. As reported in ref A, Austria concluded a pre-contract with the
U.S. pharmaceutical company Baxter to supply 16 million vaccine
doses. The Austrian health authorities expect the authorization of
Baxter's H1N1 vaccine (under the brand name "Celvapan") by
September. Baxter has developed its H1N1 vaccine by using its "vero
cell" technology (cell cultures instead of conventional egg-based
systems) in its research facilities in Austria, and is currently in
the production phase.
HOH